HeraMED Limited (ASX:HMD)
Australia
· Delayed Price · Currency is AUD 0.0410
-0.0010 (-2.38%)
At close: Mar 6, 2026
HeraMED Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 0.29 | 0.36 | 0.61 | 0.32 | 0.12 | Upgrade
|
| Other Revenue | 0.14 | - | - | - | - | Upgrade
|
| Revenue | 0.43 | 0.36 | 0.61 | 0.32 | 0.12 | Upgrade
|
| Revenue Growth (YoY) | 18.47% | -39.90% | 88.22% | 170.27% | 132.67% | Upgrade
|
| Cost of Revenue | 0.38 | 0.15 | 0.24 | 0.12 | 0.06 | Upgrade
|
| Gross Profit | 0.05 | 0.22 | 0.36 | 0.21 | 0.06 | Upgrade
|
| Selling, General & Admin | 2.51 | 3.77 | 4.22 | 2.56 | 2.47 | Upgrade
|
| Research & Development | 1.03 | 1.34 | 2.12 | 1.12 | 2.08 | Upgrade
|
| Other Operating Expenses | - | -0.12 | - | - | - | Upgrade
|
| Operating Expenses | 3.9 | 5.67 | 7.03 | 4.89 | 5.48 | Upgrade
|
| Operating Income | -3.85 | -5.45 | -6.67 | -4.68 | -5.42 | Upgrade
|
| Interest Expense | -0 | -0.05 | -0.01 | -2.18 | -2.19 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.05 | - | -0.12 | -0.37 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.4 | 0.01 | 0.03 | 0.06 | -0.1 | Upgrade
|
| EBT Excluding Unusual Items | -3.5 | -5.49 | -6.78 | -7.18 | -7.72 | Upgrade
|
| Asset Writedown | -0.63 | - | - | - | -0.13 | Upgrade
|
| Pretax Income | -4.13 | -5.49 | -6.78 | -7.18 | -7.85 | Upgrade
|
| Net Income | -4.13 | -5.49 | -6.78 | -7.18 | -7.85 | Upgrade
|
| Net Income to Common | -4.13 | -5.49 | -6.78 | -7.18 | -7.85 | Upgrade
|
| Shares Outstanding (Basic) | 1,059 | 532 | 260 | 214 | 175 | Upgrade
|
| Shares Outstanding (Diluted) | 1,059 | 532 | 260 | 214 | 175 | Upgrade
|
| Shares Change (YoY) | 99.24% | 104.14% | 21.65% | 22.61% | 38.84% | Upgrade
|
| EPS (Basic) | -0.00 | -0.01 | -0.03 | -0.03 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.01 | -0.03 | -0.03 | -0.04 | Upgrade
|
| Free Cash Flow | -3.66 | -4.81 | -5.71 | -3.77 | -4.47 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.02 | -0.03 | Upgrade
|
| Gross Margin | 11.69% | 60.00% | 60.05% | 64.24% | 51.24% | Upgrade
|
| Operating Margin | -891.10% | -1496.29% | -1100.13% | -1453.02% | -4545.69% | Upgrade
|
| Profit Margin | -957.27% | -1507.04% | -1117.60% | -2229.48% | -6588.22% | Upgrade
|
| Free Cash Flow Margin | -847.42% | -1321.45% | -942.64% | -1171.67% | -3751.19% | Upgrade
|
| EBITDA | -3.7 | -5.41 | -6.59 | -4.66 | -5.41 | Upgrade
|
| D&A For EBITDA | 0.14 | 0.04 | 0.08 | 0.02 | 0.01 | Upgrade
|
| EBIT | -3.85 | -5.45 | -6.67 | -4.68 | -5.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.